Bank of New York Mellon’s GoHealth GOCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,397
Closed -$50.1K 4219
2025
Q3
$50.1K Buy
+10,397
New +$56.7K ﹤0.01% 4131
2024
Q3
Sell
-12,982
Closed -$126K 4128
2024
Q2
$126K Buy
12,982
+1,802
+16% +$17.8K ﹤0.01% 4007
2024
Q1
$118K Sell
11,180
-770
-6% -$9.52K ﹤0.01% 4020
2023
Q4
$159K Buy
11,950
+112
+0.9% +$1.53K ﹤0.01% 4010
2023
Q3
$172K Buy
11,838
+578
+5% +$9.95K ﹤0.01% 3999
2023
Q2
$222K Buy
+11,260
New +$177K ﹤0.01% 3945
2022
Q4
Sell
-1,503
Closed -$8K 4500
2022
Q3
$8K Hold
1,503
﹤0.01% 4518
2022
Q2
$13K Sell
1,503
-9,248
-86% -$108K ﹤0.01% 4529
2022
Q1
$190K Sell
10,751
-1,563
-13% -$48.6K ﹤0.01% 4262
2021
Q4
$700K Buy
12,314
+4,001
+48% +$267K ﹤0.01% 3587
2021
Q3
$627K Buy
8,313
+79
+1% +$8.36K ﹤0.01% 3669
2021
Q2
$1.38M Buy
8,234
+241
+3% +$42.2K ﹤0.01% 3223
2021
Q1
$1.4M Sell
7,993
-181
-2% -$36.5K ﹤0.01% 3137
2020
Q4
$1.68M Buy
8,174
+3,898
+91% +$724K ﹤0.01% 2948
2020
Q3
$836K Buy
+4,276
New +$1.03M ﹤0.01% 3224

Other funds holding GOCO

Bank of New York Mellon's GOCO Position: Q4 2025 in Review

Bank of New York Mellon sold out of GoHealth (GOCO) in Q4 2025, closing a stake of 10,397 shares — an estimated $50.1K sold.

Bank of New York Mellon first reported a position in GOCO in Q3 2020 and held it in 15 quarters. The position peaked at $1.68M in Q4 2020. 56 funds tracked by Wall St. Rank hold GOCO as of Q4 2025.

  • Bank of New York Mellon reported no remaining GoHealth position as of Q4 2025 after selling out during the quarter.
  • Bank of New York Mellon sold 10,397 GoHealth shares in Q4 2025, an estimated $50.1K.
  • Bank of New York Mellon first reported a position in GoHealth in Q3 2020 and held it in 15 quarters.
  • Bank of New York Mellon's GoHealth position peaked at $1.68M in Q4 2020.
  • 56 funds tracked by Wall St. Rank held GoHealth as of Q4 2025.

Based on Bank of New York Mellon's 13F filing for Q4 2025, filed 10 Feb 2026.